Biomarkers Serum Collection Methodology Pilot Study
Completed
Conditions studied: Hemophilia A
In brief
The purpose of this study is to compare the standard collection of whole blood in tiger top tubes for serum collection versus a collection method of added FVIII to whole blood samples in the hemophilia population for routine biomarker assays to ensure reliable assay results.
Key facts
- Study ID
- NCT01318707
- Run by
- Georgetown University
- People needed
- 20
- Starts
- 2010-12-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2012-07-24
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Severe Hemophilia A
You may not qualify if…
- If they are not diagnosed with severe hemophilia A.
Where it is running
- Lombardi Cancer Center — Washington D.C., District of Columbia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.